

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.70653248 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 4.70653248 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.32607644 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 4.32607644 |
| 5 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.23389438 |
| 6 | alpha-linolenic acid metabolic process (GO:0036109) | 4.21953811 |
| 7 | cellular ketone body metabolic process (GO:0046950) | 4.21686860 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 4.21454968 |
| 9 | cysteine metabolic process (GO:0006534) | 3.82871681 |
| 10 | tryptophan catabolic process (GO:0006569) | 3.80160294 |
| 11 | indole-containing compound catabolic process (GO:0042436) | 3.80160294 |
| 12 | indolalkylamine catabolic process (GO:0046218) | 3.80160294 |
| 13 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.79136628 |
| 14 | bile acid biosynthetic process (GO:0006699) | 3.77102120 |
| 15 | cellular potassium ion homeostasis (GO:0030007) | 3.70032808 |
| 16 | urea cycle (GO:0000050) | 3.68643079 |
| 17 | urea metabolic process (GO:0019627) | 3.68643079 |
| 18 | kynurenine metabolic process (GO:0070189) | 3.66131552 |
| 19 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.62618155 |
| 20 | ketone body metabolic process (GO:1902224) | 3.61978691 |
| 21 | tryptophan metabolic process (GO:0006568) | 3.60214315 |
| 22 | glutamate metabolic process (GO:0006536) | 3.52354576 |
| 23 | high-density lipoprotein particle remodeling (GO:0034375) | 3.46646427 |
| 24 | sodium ion export (GO:0071436) | 3.45428934 |
| 25 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.44471058 |
| 26 | homocysteine metabolic process (GO:0050667) | 3.43406848 |
| 27 | lysine catabolic process (GO:0006554) | 3.41788401 |
| 28 | lysine metabolic process (GO:0006553) | 3.41788401 |
| 29 | complement activation, alternative pathway (GO:0006957) | 3.37955515 |
| 30 | glyoxylate metabolic process (GO:0046487) | 3.37644455 |
| 31 | regulation of protein activation cascade (GO:2000257) | 3.36715183 |
| 32 | nitrogen cycle metabolic process (GO:0071941) | 3.33056060 |
| 33 | cellular modified amino acid catabolic process (GO:0042219) | 3.31860161 |
| 34 | reverse cholesterol transport (GO:0043691) | 3.31410263 |
| 35 | sulfur amino acid catabolic process (GO:0000098) | 3.30891326 |
| 36 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.27843087 |
| 37 | serine family amino acid catabolic process (GO:0009071) | 3.26631413 |
| 38 | glutamate secretion (GO:0014047) | 3.22887739 |
| 39 | bile acid metabolic process (GO:0008206) | 3.21520041 |
| 40 | regulation of bile acid biosynthetic process (GO:0070857) | 3.18622680 |
| 41 | regulation of complement activation (GO:0030449) | 3.16745820 |
| 42 | amino-acid betaine metabolic process (GO:0006577) | 3.14768327 |
| 43 | alpha-amino acid catabolic process (GO:1901606) | 3.12168791 |
| 44 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.10575637 |
| 45 | negative regulation of fibrinolysis (GO:0051918) | 3.10146458 |
| 46 | plasma lipoprotein particle remodeling (GO:0034369) | 3.08136801 |
| 47 | protein-lipid complex remodeling (GO:0034368) | 3.08136801 |
| 48 | macromolecular complex remodeling (GO:0034367) | 3.08136801 |
| 49 | regulation of fibrinolysis (GO:0051917) | 3.07960253 |
| 50 | regulation of triglyceride catabolic process (GO:0010896) | 3.05518713 |
| 51 | protein carboxylation (GO:0018214) | 3.05246812 |
| 52 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.05246812 |
| 53 | triglyceride homeostasis (GO:0070328) | 3.02510297 |
| 54 | acylglycerol homeostasis (GO:0055090) | 3.02510297 |
| 55 | tyrosine metabolic process (GO:0006570) | 2.99517805 |
| 56 | coenzyme catabolic process (GO:0009109) | 2.95439020 |
| 57 | cellular amino acid catabolic process (GO:0009063) | 2.95354543 |
| 58 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.93858176 |
| 59 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.93503839 |
| 60 | L-amino acid import (GO:0043092) | 2.92060914 |
| 61 | gamma-aminobutyric acid transport (GO:0015812) | 2.91406590 |
| 62 | aromatic amino acid family metabolic process (GO:0009072) | 2.91172679 |
| 63 | positive regulation of fatty acid oxidation (GO:0046321) | 2.90533778 |
| 64 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.88097599 |
| 65 | short-chain fatty acid metabolic process (GO:0046459) | 2.87232465 |
| 66 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.86359281 |
| 67 | amino acid import (GO:0043090) | 2.85446955 |
| 68 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.84195711 |
| 69 | postsynaptic membrane organization (GO:0001941) | 2.82138090 |
| 70 | phospholipid homeostasis (GO:0055091) | 2.80848992 |
| 71 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.76454014 |
| 72 | negative regulation of protein activation cascade (GO:2000258) | 2.74897378 |
| 73 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.74548674 |
| 74 | aspartate family amino acid catabolic process (GO:0009068) | 2.74275093 |
| 75 | linoleic acid metabolic process (GO:0043651) | 2.72262123 |
| 76 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.72185177 |
| 77 | positive regulation of lipid catabolic process (GO:0050996) | 2.72169154 |
| 78 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.71780172 |
| 79 | cholesterol efflux (GO:0033344) | 2.69977602 |
| 80 | drug catabolic process (GO:0042737) | 2.69761301 |
| 81 | regulation of acrosome reaction (GO:0060046) | 2.68988852 |
| 82 | dicarboxylic acid catabolic process (GO:0043649) | 2.68554775 |
| 83 | synaptic vesicle maturation (GO:0016188) | 2.65731520 |
| 84 | negative regulation of lipase activity (GO:0060192) | 2.64902283 |
| 85 | regulation of cholesterol esterification (GO:0010872) | 2.64687381 |
| 86 | phospholipid efflux (GO:0033700) | 2.64262414 |
| 87 | fatty acid transmembrane transport (GO:1902001) | 2.63987764 |
| 88 | indolalkylamine metabolic process (GO:0006586) | 2.63902019 |
| 89 | myelination in peripheral nervous system (GO:0022011) | 2.62476173 |
| 90 | peripheral nervous system axon ensheathment (GO:0032292) | 2.62476173 |
| 91 | low-density lipoprotein particle remodeling (GO:0034374) | 2.61927816 |
| 92 | cerebellar granule cell differentiation (GO:0021707) | 2.61261808 |
| 93 | regulation of cholesterol homeostasis (GO:2000188) | 2.60527797 |
| 94 | cellular sodium ion homeostasis (GO:0006883) | 2.59831778 |
| 95 | fatty acid beta-oxidation (GO:0006635) | 2.58561345 |
| 96 | bile acid and bile salt transport (GO:0015721) | 2.57816235 |
| 97 | 2-oxoglutarate metabolic process (GO:0006103) | 2.56053325 |
| 98 | organic acid catabolic process (GO:0016054) | 2.55591054 |
| 99 | carboxylic acid catabolic process (GO:0046395) | 2.55591054 |
| 100 | very long-chain fatty acid metabolic process (GO:0000038) | 2.53718206 |
| 101 | cellular biogenic amine catabolic process (GO:0042402) | 2.53611965 |
| 102 | amine catabolic process (GO:0009310) | 2.53611965 |
| 103 | lipid oxidation (GO:0034440) | 2.52628047 |
| 104 | monocarboxylic acid catabolic process (GO:0072329) | 2.52354884 |
| 105 | extracellular matrix assembly (GO:0085029) | 2.52297756 |
| 106 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.52257560 |
| 107 | fatty acid oxidation (GO:0019395) | 2.52193753 |
| 108 | metanephric nephron tubule development (GO:0072234) | 2.52093975 |
| 109 | metanephric tubule development (GO:0072170) | 2.52093975 |
| 110 | acetyl-CoA metabolic process (GO:0006084) | 2.50906572 |
| 111 | carnitine shuttle (GO:0006853) | 2.47742510 |
| 112 | biotin metabolic process (GO:0006768) | 2.47616399 |
| 113 | plasma lipoprotein particle clearance (GO:0034381) | 2.46589244 |
| 114 | protein heterotrimerization (GO:0070208) | 2.46541466 |
| 115 | cell communication by electrical coupling (GO:0010644) | 2.45785735 |
| 116 | nucleobase catabolic process (GO:0046113) | 2.45683245 |
| 117 | fructose metabolic process (GO:0006000) | 2.45259769 |
| 118 | exogenous drug catabolic process (GO:0042738) | 2.44923001 |
| 119 | fatty acid catabolic process (GO:0009062) | 2.44645324 |
| 120 | drug transmembrane transport (GO:0006855) | 2.43823487 |
| 121 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.43609942 |
| 122 | cell-substrate junction assembly (GO:0007044) | 2.43160253 |
| 123 | plasma lipoprotein particle assembly (GO:0034377) | 2.42877683 |
| 124 | plasma lipoprotein particle organization (GO:0071827) | 2.40916960 |
| 125 | dermatan sulfate biosynthetic process (GO:0030208) | 2.40262494 |
| 126 | vocalization behavior (GO:0071625) | 2.39844899 |
| 127 | skin morphogenesis (GO:0043589) | 2.39824907 |
| 128 | focal adhesion assembly (GO:0048041) | 2.39553352 |
| 129 | cell-substrate adherens junction assembly (GO:0007045) | 2.39553352 |
| 130 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.39526200 |
| 131 | regulation of ARF protein signal transduction (GO:0032012) | 2.39488813 |
| 132 | arginine metabolic process (GO:0006525) | 2.39443466 |
| 133 | flavonoid metabolic process (GO:0009812) | 2.38726973 |
| 134 | potassium ion homeostasis (GO:0055075) | 2.36533963 |
| 135 | negative regulation of fatty acid transport (GO:2000192) | 2.36427978 |
| 136 | negative regulation of protein localization to cell surface (GO:2000009) | 2.36426575 |
| 137 | potassium ion import (GO:0010107) | 2.35871890 |
| 138 | metanephric nephron epithelium development (GO:0072243) | 2.30057466 |
| 139 | synaptic vesicle exocytosis (GO:0016079) | 2.28261040 |
| 140 | neuronal ion channel clustering (GO:0045161) | 2.27927688 |
| 141 | kidney mesenchyme development (GO:0072074) | 2.27920769 |
| 142 | dermatan sulfate metabolic process (GO:0030205) | 2.26899976 |
| 143 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.26608505 |
| 144 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.25677742 |
| 145 | adherens junction assembly (GO:0034333) | 2.25175875 |
| 146 | collagen fibril organization (GO:0030199) | 2.24535724 |
| 147 | locomotory exploration behavior (GO:0035641) | 2.24128159 |
| 148 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.23257751 |
| 149 | cell migration involved in heart development (GO:0060973) | 2.22556698 |
| 150 | astrocyte differentiation (GO:0048708) | 2.21543775 |
| 151 | actin filament depolymerization (GO:0030042) | 2.19775704 |
| 152 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.19741609 |
| 153 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.19591048 |
| 154 | camera-type eye morphogenesis (GO:0048593) | 2.19484486 |
| 155 | neuron projection extension (GO:1990138) | 2.18024839 |
| 156 | positive regulation of synapse maturation (GO:0090129) | 2.17609713 |
| 157 | macroautophagy (GO:0016236) | 2.16354704 |
| 158 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.15117376 |
| 159 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.14825510 |
| 160 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.13919552 |
| 161 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.13295816 |
| 162 | axon extension (GO:0048675) | 2.13024976 |
| 163 | metanephric mesenchyme development (GO:0072075) | 2.12660700 |
| 164 | plasma membrane repair (GO:0001778) | 2.10791260 |
| 165 | protein targeting to plasma membrane (GO:0072661) | 2.10493365 |
| 166 | hemidesmosome assembly (GO:0031581) | 2.10340606 |
| 167 | developmental cell growth (GO:0048588) | 2.09797407 |
| 168 | membrane assembly (GO:0071709) | 2.09480977 |
| 169 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.09197698 |
| 170 | cell volume homeostasis (GO:0006884) | 2.08485979 |
| 171 | myoblast fusion (GO:0007520) | 2.07903707 |
| 172 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.07680028 |
| 173 | activation of protein kinase A activity (GO:0034199) | 2.06443091 |
| 174 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.06404361 |
| 175 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.06249571 |
| 176 | positive regulation of axon extension (GO:0045773) | 2.05825364 |
| 177 | import into cell (GO:0098657) | 2.05450713 |
| 178 | metanephric epithelium development (GO:0072207) | 2.04932752 |
| 179 | axonal fasciculation (GO:0007413) | 2.04885322 |
| 180 | positive regulation of fibroblast migration (GO:0010763) | 2.04706266 |
| 181 | astrocyte development (GO:0014002) | 2.02549299 |
| 182 | endocardial cushion development (GO:0003197) | 2.00975162 |
| 183 | barbed-end actin filament capping (GO:0051016) | 1.99945839 |
| 184 | central nervous system myelination (GO:0022010) | 1.99884638 |
| 185 | axon ensheathment in central nervous system (GO:0032291) | 1.99884638 |
| 186 | regulation of female gonad development (GO:2000194) | 1.99687190 |
| 187 | cerebellar Purkinje cell layer development (GO:0021680) | 1.98828153 |
| 188 | chondroitin sulfate catabolic process (GO:0030207) | 1.97182822 |
| 189 | cell adhesion mediated by integrin (GO:0033627) | 1.96279809 |
| 190 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 1.96110430 |
| 191 | endodermal cell differentiation (GO:0035987) | 1.95992341 |
| 192 | regulation of cell communication by electrical coupling (GO:0010649) | 1.94222081 |
| 193 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 1.94186271 |
| 194 | negative regulation of hormone metabolic process (GO:0032351) | 1.93513210 |
| 195 | positive regulation of dendritic spine development (GO:0060999) | 1.93490665 |
| 196 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 1.93353986 |
| 197 | cardiac myofibril assembly (GO:0055003) | 1.92560909 |
| 198 | neuronal action potential propagation (GO:0019227) | 1.92484853 |
| 199 | negative regulation of dendrite morphogenesis (GO:0050774) | 1.92185426 |
| 200 | ensheathment of neurons (GO:0007272) | 1.91995478 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.05717641 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.67082449 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.06629097 |
| 4 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.78556118 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.75431985 |
| 6 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.74964616 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.42284548 |
| 8 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.37427811 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.21667877 |
| 10 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.18288684 |
| 11 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.16064559 |
| 12 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.15168692 |
| 13 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.12001882 |
| 14 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.02135368 |
| 15 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.93808788 |
| 16 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.87354567 |
| 17 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.85017433 |
| 18 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.67657572 |
| 19 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.65130570 |
| 20 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.64953605 |
| 21 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.64953605 |
| 22 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.63224630 |
| 23 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.62033435 |
| 24 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.61019943 |
| 25 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.59127775 |
| 26 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.56998420 |
| 27 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.56676065 |
| 28 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.56241151 |
| 29 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.55690616 |
| 30 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.52316087 |
| 31 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.51479424 |
| 32 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.50722990 |
| 33 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.49724058 |
| 34 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.49583913 |
| 35 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.49159061 |
| 36 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.46661874 |
| 37 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.46172684 |
| 38 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.45936006 |
| 39 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.44411026 |
| 40 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.43043072 |
| 41 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.42212140 |
| 42 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.40203520 |
| 43 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.39163586 |
| 44 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.38847482 |
| 45 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.38545529 |
| 46 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.38301936 |
| 47 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.35961222 |
| 48 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.35287830 |
| 49 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.35206529 |
| 50 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.32133731 |
| 51 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.31772227 |
| 52 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.31560993 |
| 53 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.31379981 |
| 54 | KDM2B_26808549_Chip-Seq_K562_Human | 1.31271993 |
| 55 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.31252305 |
| 56 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.30603494 |
| 57 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.30115069 |
| 58 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.29324955 |
| 59 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.28625834 |
| 60 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.28388187 |
| 61 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.27972078 |
| 62 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.27972078 |
| 63 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.27223433 |
| 64 | CJUN_26792858_Chip-Seq_BT549_Human | 1.27160609 |
| 65 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.26907258 |
| 66 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.25121952 |
| 67 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.23836597 |
| 68 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.22750179 |
| 69 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.20933059 |
| 70 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.20931263 |
| 71 | P300_19829295_ChIP-Seq_ESCs_Human | 1.19387810 |
| 72 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.19115623 |
| 73 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.18914757 |
| 74 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.16569615 |
| 75 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.16514234 |
| 76 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.16369959 |
| 77 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.15963790 |
| 78 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.15678405 |
| 79 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.14692361 |
| 80 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.14051849 |
| 81 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.13185702 |
| 82 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.12679472 |
| 83 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.12643578 |
| 84 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.11519115 |
| 85 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.11477577 |
| 86 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.10710580 |
| 87 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.10693408 |
| 88 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.10325667 |
| 89 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.08510151 |
| 90 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.08327406 |
| 91 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.06975309 |
| 92 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.06621079 |
| 93 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.06222093 |
| 94 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.06130027 |
| 95 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.06113653 |
| 96 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.05412294 |
| 97 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.05080253 |
| 98 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.04485686 |
| 99 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.04089951 |
| 100 | * AR_19668381_ChIP-Seq_PC3_Human | 1.03755353 |
| 101 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.02965234 |
| 102 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.02583150 |
| 103 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.01400502 |
| 104 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00200256 |
| 105 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.00200256 |
| 106 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.99720711 |
| 107 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.99501142 |
| 108 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.99407877 |
| 109 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.98740350 |
| 110 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.97685100 |
| 111 | TP53_16413492_ChIP-PET_HCT116_Human | 0.96999546 |
| 112 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.96921928 |
| 113 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.96412231 |
| 114 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.96320131 |
| 115 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.95942522 |
| 116 | RXR_22108803_ChIP-Seq_LS180_Human | 0.95920070 |
| 117 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.95749560 |
| 118 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.95584667 |
| 119 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.95421436 |
| 120 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.95285185 |
| 121 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.93838472 |
| 122 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.93613090 |
| 123 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.93601035 |
| 124 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.93601035 |
| 125 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.93582346 |
| 126 | * MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.93565508 |
| 127 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.93309353 |
| 128 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.92782626 |
| 129 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.92627208 |
| 130 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.92070609 |
| 131 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.91779602 |
| 132 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.90425573 |
| 133 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.90404886 |
| 134 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.89976017 |
| 135 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.89694939 |
| 136 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.89224872 |
| 137 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.89044869 |
| 138 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.88793636 |
| 139 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.88408915 |
| 140 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.87734646 |
| 141 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.87256592 |
| 142 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.87171245 |
| 143 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.86987214 |
| 144 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.86480998 |
| 145 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.85100896 |
| 146 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.84698664 |
| 147 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.84522387 |
| 148 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.84180532 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.57583732 |
| 2 | MP0005360_urolithiasis | 5.42059737 |
| 3 | MP0005365_abnormal_bile_salt | 4.64125241 |
| 4 | MP0008438_abnormal_cutaneous_collagen | 4.37397012 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 4.31340637 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.24539635 |
| 7 | MP0003252_abnormal_bile_duct | 3.23943410 |
| 8 | MP0001958_emphysema | 2.80021738 |
| 9 | MP0010329_abnormal_lipoprotein_level | 2.70304998 |
| 10 | MP0005503_abnormal_tendon_morphology | 2.68457953 |
| 11 | MP0005275_abnormal_skin_tensile | 2.37327629 |
| 12 | MP0003195_calcinosis | 2.29231290 |
| 13 | MP0009780_abnormal_chondrocyte_physiolo | 2.28934524 |
| 14 | MP0003950_abnormal_plasma_membrane | 2.20681283 |
| 15 | MP0005332_abnormal_amino_acid | 2.18076567 |
| 16 | MP0003868_abnormal_feces_composition | 2.12264921 |
| 17 | MP0004859_abnormal_synaptic_plasticity | 2.11349893 |
| 18 | MP0004272_abnormal_basement_membrane | 1.93940930 |
| 19 | MP0003279_aneurysm | 1.87486711 |
| 20 | MP0005670_abnormal_white_adipose | 1.86604227 |
| 21 | MP0005623_abnormal_meninges_morphology | 1.81403777 |
| 22 | MP0005409_darkened_coat_color | 1.80145985 |
| 23 | MP0002837_dystrophic_cardiac_calcinosis | 1.76046311 |
| 24 | MP0004270_analgesia | 1.70185823 |
| 25 | MP0002118_abnormal_lipid_homeostasis | 1.70058018 |
| 26 | MP0004130_abnormal_muscle_cell | 1.67945737 |
| 27 | MP0004885_abnormal_endolymph | 1.67858084 |
| 28 | MP0005257_abnormal_intraocular_pressure | 1.66484981 |
| 29 | MP0003635_abnormal_synaptic_transmissio | 1.61309722 |
| 30 | MP0001666_abnormal_nutrient_absorption | 1.60765772 |
| 31 | MP0000749_muscle_degeneration | 1.60715710 |
| 32 | MP0005083_abnormal_biliary_tract | 1.60437133 |
| 33 | MP0002876_abnormal_thyroid_physiology | 1.50194683 |
| 34 | MP0004043_abnormal_pH_regulation | 1.45737235 |
| 35 | MP0001299_abnormal_eye_distance/ | 1.41143511 |
| 36 | MP0005646_abnormal_pituitary_gland | 1.40446458 |
| 37 | MP0004019_abnormal_vitamin_homeostasis | 1.39369553 |
| 38 | MP0000759_abnormal_skeletal_muscle | 1.37969677 |
| 39 | MP0000534_abnormal_ureter_morphology | 1.37596084 |
| 40 | MP0003566_abnormal_cell_adhesion | 1.36848727 |
| 41 | MP0004036_abnormal_muscle_relaxation | 1.36147436 |
| 42 | MP0002063_abnormal_learning/memory/cond | 1.35613821 |
| 43 | MP0003091_abnormal_cell_migration | 1.35311393 |
| 44 | MP0001486_abnormal_startle_reflex | 1.34645919 |
| 45 | MP0002896_abnormal_bone_mineralization | 1.34636891 |
| 46 | MP0009046_muscle_twitch | 1.32964579 |
| 47 | MP0000733_abnormal_muscle_development | 1.32548060 |
| 48 | MP0004233_abnormal_muscle_weight | 1.32431378 |
| 49 | MP0009745_abnormal_behavioral_response | 1.29574041 |
| 50 | MP0002822_catalepsy | 1.28373855 |
| 51 | MP0000747_muscle_weakness | 1.27370114 |
| 52 | MP0009384_cardiac_valve_regurgitation | 1.26195145 |
| 53 | MP0000003_abnormal_adipose_tissue | 1.26156047 |
| 54 | MP0003690_abnormal_glial_cell | 1.24535579 |
| 55 | MP0002064_seizures | 1.22087980 |
| 56 | MP0003283_abnormal_digestive_organ | 1.20051391 |
| 57 | MP0002572_abnormal_emotion/affect_behav | 1.19259054 |
| 58 | MP0010368_abnormal_lymphatic_system | 1.18654678 |
| 59 | MP0005023_abnormal_wound_healing | 1.16012059 |
| 60 | MP0005647_abnormal_sex_gland | 1.15043826 |
| 61 | MP0000609_abnormal_liver_physiology | 1.14096895 |
| 62 | MP0005535_abnormal_body_temperature | 1.13479102 |
| 63 | MP0000920_abnormal_myelination | 1.12129686 |
| 64 | MP0000566_synostosis | 1.09321206 |
| 65 | MP0004087_abnormal_muscle_fiber | 1.09279346 |
| 66 | MP0002295_abnormal_pulmonary_circulatio | 1.08177851 |
| 67 | MP0005551_abnormal_eye_electrophysiolog | 1.07490515 |
| 68 | MP0002249_abnormal_larynx_morphology | 1.07406917 |
| 69 | MP0001501_abnormal_sleep_pattern | 1.05328512 |
| 70 | MP0001984_abnormal_olfaction | 1.04648146 |
| 71 | MP0003880_abnormal_central_pattern | 1.04282764 |
| 72 | MP0005187_abnormal_penis_morphology | 1.03974925 |
| 73 | MP0001502_abnormal_circadian_rhythm | 1.03929207 |
| 74 | MP0003806_abnormal_nucleotide_metabolis | 1.03860756 |
| 75 | MP0002060_abnormal_skin_morphology | 1.02008003 |
| 76 | MP0003329_amyloid_beta_deposits | 1.01180476 |
| 77 | MP0002269_muscular_atrophy | 1.00934836 |
| 78 | MP0002138_abnormal_hepatobiliary_system | 1.00760773 |
| 79 | MP0008961_abnormal_basal_metabolism | 0.99803513 |
| 80 | MP0001177_atelectasis | 0.99584764 |
| 81 | MP0002272_abnormal_nervous_system | 0.98948054 |
| 82 | MP0005508_abnormal_skeleton_morphology | 0.98600394 |
| 83 | MP0000762_abnormal_tongue_morphology | 0.98330373 |
| 84 | MP0010386_abnormal_urinary_bladder | 0.98294215 |
| 85 | MP0002909_abnormal_adrenal_gland | 0.98047443 |
| 86 | MP0004084_abnormal_cardiac_muscle | 0.97536056 |
| 87 | MP0003045_fibrosis | 0.97424765 |
| 88 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.96492902 |
| 89 | MP0005423_abnormal_somatic_nervous | 0.95511540 |
| 90 | MP0009250_abnormal_appendicular_skeleto | 0.94736907 |
| 91 | MP0001348_abnormal_lacrimal_gland | 0.94645730 |
| 92 | MP0003633_abnormal_nervous_system | 0.93277662 |
| 93 | MP0003634_abnormal_glial_cell | 0.92894329 |
| 94 | MP0002971_abnormal_brown_adipose | 0.92360188 |
| 95 | MP0002078_abnormal_glucose_homeostasis | 0.91855585 |
| 96 | MP0000751_myopathy | 0.91184382 |
| 97 | MP0002734_abnormal_mechanical_nocicepti | 0.90871613 |
| 98 | MP0000462_abnormal_digestive_system | 0.90153678 |
| 99 | MP0010030_abnormal_orbit_morphology | 0.89949574 |
| 100 | MP0000013_abnormal_adipose_tissue | 0.89900651 |
| 101 | MP0000767_abnormal_smooth_muscle | 0.89659869 |
| 102 | MP0004134_abnormal_chest_morphology | 0.89209889 |
| 103 | MP0005620_abnormal_muscle_contractility | 0.88853762 |
| 104 | MP0002067_abnormal_sensory_capabilities | 0.88789100 |
| 105 | MP0004215_abnormal_myocardial_fiber | 0.87731714 |
| 106 | MP0009697_abnormal_copulation | 0.87122987 |
| 107 | MP0005369_muscle_phenotype | 0.86355132 |
| 108 | MP0000428_abnormal_craniofacial_morphol | 0.85597156 |
| 109 | MP0003191_abnormal_cellular_cholesterol | 0.85084222 |
| 110 | MP0005666_abnormal_adipose_tissue | 0.84771809 |
| 111 | MP0001440_abnormal_grooming_behavior | 0.84017713 |
| 112 | MP0005319_abnormal_enzyme/_coenzyme | 0.83934932 |
| 113 | MP0005375_adipose_tissue_phenotype | 0.83486706 |
| 114 | MP0000778_abnormal_nervous_system | 0.82077758 |
| 115 | MP0003705_abnormal_hypodermis_morpholog | 0.81496484 |
| 116 | MP0003879_abnormal_hair_cell | 0.81450316 |
| 117 | MP0004858_abnormal_nervous_system | 0.80528536 |
| 118 | MP0006138_congestive_heart_failure | 0.80039765 |
| 119 | MP0004085_abnormal_heartbeat | 0.79694803 |
| 120 | MP0004145_abnormal_muscle_electrophysio | 0.78699378 |
| 121 | MP0004924_abnormal_behavior | 0.78202863 |
| 122 | MP0005386_behavior/neurological_phenoty | 0.78202863 |
| 123 | MP0002557_abnormal_social/conspecific_i | 0.77448122 |
| 124 | MP0002108_abnormal_muscle_morphology | 0.76706845 |
| 125 | MP0001764_abnormal_homeostasis | 0.76512497 |
| 126 | MP0001879_abnormal_lymphatic_vessel | 0.75950978 |
| 127 | MP0002089_abnormal_postnatal_growth/wei | 0.75887822 |
| 128 | MP0006276_abnormal_autonomic_nervous | 0.75752676 |
| 129 | MP0005334_abnormal_fat_pad | 0.75473662 |
| 130 | MP0005595_abnormal_vascular_smooth | 0.75282864 |
| 131 | MP0003942_abnormal_urinary_system | 0.75272867 |
| 132 | MP0009840_abnormal_foam_cell | 0.74515646 |
| 133 | MP0003011_delayed_dark_adaptation | 0.74306833 |
| 134 | MP0000579_abnormal_nail_morphology | 0.72481266 |
| 135 | MP0001542_abnormal_bone_strength | 0.72468419 |
| 136 | MP0003631_nervous_system_phenotype | 0.72312034 |
| 137 | MP0002106_abnormal_muscle_physiology | 0.71428532 |
| 138 | MP0002234_abnormal_pharynx_morphology | 0.71244629 |
| 139 | MP0000163_abnormal_cartilage_morphology | 0.70610821 |
| 140 | MP0008569_lethality_at_weaning | 0.69747473 |
| 141 | MP0002168_other_aberrant_phenotype | 0.69701815 |
| 142 | MP0003953_abnormal_hormone_level | 0.69622776 |
| 143 | MP0009643_abnormal_urine_homeostasis | 0.69140498 |
| 144 | MP0000639_abnormal_adrenal_gland | 0.68251141 |
| 145 | MP0000604_amyloidosis | 0.67782858 |
| 146 | MP0002066_abnormal_motor_capabilities/c | 0.67299022 |
| 147 | MP0005220_abnormal_exocrine_pancreas | 0.66320881 |
| 148 | MP0005171_absent_coat_pigmentation | 0.65999261 |
| 149 | MP0003646_muscle_fatigue | 0.65696680 |
| 150 | MP0005377_hearing/vestibular/ear_phenot | 0.65323524 |
| 151 | MP0003878_abnormal_ear_physiology | 0.65323524 |
| 152 | MP0000230_abnormal_systemic_arterial | 0.65147247 |
| 153 | MP0003137_abnormal_impulse_conducting | 0.65145317 |
| 154 | MP0001968_abnormal_touch/_nociception | 0.64110488 |
| 155 | MP0001661_extended_life_span | 0.64025032 |
| 156 | MP0001270_distended_abdomen | 0.64025028 |
| 157 | MP0005448_abnormal_energy_balance | 0.63887555 |
| 158 | MP0005248_abnormal_Harderian_gland | 0.63327347 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 4.88517122 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 4.78888486 |
| 3 | Protrusio acetabuli (HP:0003179) | 4.75289767 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.28332654 |
| 5 | Xanthomatosis (HP:0000991) | 4.07871676 |
| 6 | Premature rupture of membranes (HP:0001788) | 4.05648382 |
| 7 | Type 1 muscle fiber predominance (HP:0003803) | 4.00143842 |
| 8 | Prolonged partial thromboplastin time (HP:0003645) | 3.96839326 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 3.93547027 |
| 10 | Hypoalphalipoproteinemia (HP:0003233) | 3.77828436 |
| 11 | Epidermoid cyst (HP:0200040) | 3.75653368 |
| 12 | Complement deficiency (HP:0004431) | 3.68867152 |
| 13 | Ketosis (HP:0001946) | 3.61934568 |
| 14 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.59207898 |
| 15 | Hypobetalipoproteinemia (HP:0003563) | 3.41021923 |
| 16 | Hypolipoproteinemia (HP:0010981) | 3.38965487 |
| 17 | Aortic aneurysm (HP:0004942) | 3.37897369 |
| 18 | Shallow orbits (HP:0000586) | 3.35492196 |
| 19 | Hyperglycinuria (HP:0003108) | 3.31361031 |
| 20 | Hyperventilation (HP:0002883) | 3.23328455 |
| 21 | Ketoacidosis (HP:0001993) | 3.23114104 |
| 22 | Hyperglycinemia (HP:0002154) | 3.23063187 |
| 23 | Vascular tortuosity (HP:0004948) | 3.22330008 |
| 24 | Hyperammonemia (HP:0001987) | 3.18887461 |
| 25 | Abnormality of glycine metabolism (HP:0010895) | 3.17200691 |
| 26 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.17200691 |
| 27 | Ankle contracture (HP:0006466) | 3.12920298 |
| 28 | Spinal rigidity (HP:0003306) | 3.11946209 |
| 29 | Obstructive sleep apnea (HP:0002870) | 3.04558266 |
| 30 | Hypoglycemic coma (HP:0001325) | 3.02715985 |
| 31 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.02683793 |
| 32 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.99187325 |
| 33 | Conjugated hyperbilirubinemia (HP:0002908) | 2.86214150 |
| 34 | Aortic dissection (HP:0002647) | 2.85639078 |
| 35 | Arterial tortuosity (HP:0005116) | 2.81538520 |
| 36 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.79509637 |
| 37 | Increased variability in muscle fiber diameter (HP:0003557) | 2.77390072 |
| 38 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.75607113 |
| 39 | Bladder diverticulum (HP:0000015) | 2.75413168 |
| 40 | Neonatal short-limb short stature (HP:0008921) | 2.66198573 |
| 41 | Hypoglycemic seizures (HP:0002173) | 2.62288677 |
| 42 | Focal motor seizures (HP:0011153) | 2.61080480 |
| 43 | Broad metatarsal (HP:0001783) | 2.59645278 |
| 44 | Hyporeflexia of lower limbs (HP:0002600) | 2.58605733 |
| 45 | Overgrowth (HP:0001548) | 2.56980258 |
| 46 | Bundle branch block (HP:0011710) | 2.56742944 |
| 47 | Abnormality of the common coagulation pathway (HP:0010990) | 2.56694205 |
| 48 | Wormian bones (HP:0002645) | 2.54885406 |
| 49 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.53390428 |
| 50 | Atrophic scars (HP:0001075) | 2.52329240 |
| 51 | Gout (HP:0001997) | 2.51795601 |
| 52 | Abnormality of methionine metabolism (HP:0010901) | 2.51386452 |
| 53 | Joint hemorrhage (HP:0005261) | 2.51005156 |
| 54 | Fat malabsorption (HP:0002630) | 2.49625417 |
| 55 | Blue irides (HP:0000635) | 2.47419148 |
| 56 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.39658912 |
| 57 | Slender build (HP:0001533) | 2.38793767 |
| 58 | Increased connective tissue (HP:0009025) | 2.38544862 |
| 59 | Hyperglycemia (HP:0003074) | 2.37982878 |
| 60 | Cerebral aneurysm (HP:0004944) | 2.36782218 |
| 61 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.35446808 |
| 62 | Mitral stenosis (HP:0001718) | 2.30016016 |
| 63 | Round ear (HP:0100830) | 2.29389927 |
| 64 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.28242207 |
| 65 | Skin nodule (HP:0200036) | 2.28110898 |
| 66 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.27910344 |
| 67 | Abnormality of complement system (HP:0005339) | 2.27003280 |
| 68 | Hypercholesterolemia (HP:0003124) | 2.26105868 |
| 69 | Neurofibrillary tangles (HP:0002185) | 2.26086064 |
| 70 | Bowel diverticulosis (HP:0005222) | 2.25805835 |
| 71 | Muscle fiber inclusion bodies (HP:0100299) | 2.25417103 |
| 72 | Enlarged kidneys (HP:0000105) | 2.25373365 |
| 73 | Follicular hyperkeratosis (HP:0007502) | 2.23820013 |
| 74 | Hyperacusis (HP:0010780) | 2.23243770 |
| 75 | Hypochromic microcytic anemia (HP:0004840) | 2.19446856 |
| 76 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.19020764 |
| 77 | Fragile skin (HP:0001030) | 2.18515980 |
| 78 | Nemaline bodies (HP:0003798) | 2.17703545 |
| 79 | Myocardial infarction (HP:0001658) | 2.16218865 |
| 80 | Delayed CNS myelination (HP:0002188) | 2.14702753 |
| 81 | Progressive cerebellar ataxia (HP:0002073) | 2.14046662 |
| 82 | Alkalosis (HP:0001948) | 2.13712203 |
| 83 | Abnormality of the intrinsic pathway (HP:0010989) | 2.13512554 |
| 84 | Abnormality of purine metabolism (HP:0004352) | 2.11222738 |
| 85 | Exercise-induced myalgia (HP:0003738) | 2.10485511 |
| 86 | Status epilepticus (HP:0002133) | 2.09115474 |
| 87 | Metabolic acidosis (HP:0001942) | 2.08018675 |
| 88 | Abnormality of the lower motor neuron (HP:0002366) | 2.07470373 |
| 89 | Soft skin (HP:0000977) | 2.07335531 |
| 90 | Ulnar bowing (HP:0003031) | 2.06756649 |
| 91 | Focal seizures (HP:0007359) | 2.06440083 |
| 92 | Mitral regurgitation (HP:0001653) | 2.06362862 |
| 93 | Cerebral inclusion bodies (HP:0100314) | 2.03387281 |
| 94 | Confusion (HP:0001289) | 2.01636630 |
| 95 | Hyperextensible skin (HP:0000974) | 2.01358222 |
| 96 | Chronic hepatic failure (HP:0100626) | 2.00175015 |
| 97 | Vertebral compression fractures (HP:0002953) | 1.98600858 |
| 98 | Advanced eruption of teeth (HP:0006288) | 1.97970933 |
| 99 | Hyperbilirubinemia (HP:0002904) | 1.97794587 |
| 100 | Wrist flexion contracture (HP:0001239) | 1.97572005 |
| 101 | Hypokalemic alkalosis (HP:0001949) | 1.96967781 |
| 102 | Hypoplasia of the iris (HP:0007676) | 1.96316955 |
| 103 | Hypoventilation (HP:0002791) | 1.95539486 |
| 104 | Renovascular hypertension (HP:0100817) | 1.95032472 |
| 105 | Aplasia involving bones of the extremities (HP:0009825) | 1.94254521 |
| 106 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.94254521 |
| 107 | Aplasia of the phalanges of the hand (HP:0009802) | 1.94254521 |
| 108 | Insomnia (HP:0100785) | 1.94130366 |
| 109 | Supranuclear gaze palsy (HP:0000605) | 1.92910599 |
| 110 | Abnormality of serum amino acid levels (HP:0003112) | 1.92281017 |
| 111 | Genu recurvatum (HP:0002816) | 1.90436815 |
| 112 | Turricephaly (HP:0000262) | 1.89512101 |
| 113 | Spontaneous abortion (HP:0005268) | 1.89351609 |
| 114 | Action tremor (HP:0002345) | 1.88384919 |
| 115 | Cervical subluxation (HP:0003308) | 1.87312964 |
| 116 | Fair hair (HP:0002286) | 1.86109180 |
| 117 | Natal tooth (HP:0000695) | 1.85903347 |
| 118 | Distal lower limb muscle weakness (HP:0009053) | 1.85794825 |
| 119 | Aneurysm (HP:0002617) | 1.85594629 |
| 120 | Hepatocellular carcinoma (HP:0001402) | 1.84523130 |
| 121 | Scanning speech (HP:0002168) | 1.84224628 |
| 122 | Spinal cord compression (HP:0002176) | 1.83294491 |
| 123 | Difficulty running (HP:0009046) | 1.83212752 |
| 124 | Coronal craniosynostosis (HP:0004440) | 1.82762503 |
| 125 | Neonatal onset (HP:0003623) | 1.82433024 |
| 126 | Hyperactive renin-angiotensin system (HP:0000841) | 1.81768020 |
| 127 | Hepatoblastoma (HP:0002884) | 1.81717932 |
| 128 | Back pain (HP:0003418) | 1.81237619 |
| 129 | Symptomatic seizures (HP:0011145) | 1.79969581 |
| 130 | Febrile seizures (HP:0002373) | 1.79919712 |
| 131 | Joint laxity (HP:0001388) | 1.79545590 |
| 132 | Dysmetric saccades (HP:0000641) | 1.78179094 |
| 133 | Hyperuricemia (HP:0002149) | 1.77838778 |
| 134 | Increased purine levels (HP:0004368) | 1.77838778 |
| 135 | Blue sclerae (HP:0000592) | 1.76861646 |
| 136 | Increased circulating renin level (HP:0000848) | 1.76730295 |
| 137 | Dysdiadochokinesis (HP:0002075) | 1.76678622 |
| 138 | Generalized tonic-clonic seizures (HP:0002069) | 1.76496027 |
| 139 | Abnormal atrioventricular conduction (HP:0005150) | 1.76067634 |
| 140 | Mild short stature (HP:0003502) | 1.75621856 |
| 141 | Upper limb amyotrophy (HP:0009129) | 1.75522348 |
| 142 | Distal upper limb amyotrophy (HP:0007149) | 1.75522348 |
| 143 | Impaired vibratory sensation (HP:0002495) | 1.75360658 |
| 144 | Bradycardia (HP:0001662) | 1.74665317 |
| 145 | Truncal ataxia (HP:0002078) | 1.73804375 |
| 146 | Torticollis (HP:0000473) | 1.72995404 |
| 147 | Chorioretinal atrophy (HP:0000533) | 1.72782569 |
| 148 | Lower limb amyotrophy (HP:0007210) | 1.72549822 |
| 149 | Scapular winging (HP:0003691) | 1.71496120 |
| 150 | Sensorimotor neuropathy (HP:0007141) | 1.70304387 |
| 151 | Limited hip movement (HP:0008800) | 1.69859164 |
| 152 | Mitral valve prolapse (HP:0001634) | 1.69323405 |
| 153 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.69197131 |
| 154 | Abnormality of nucleobase metabolism (HP:0010932) | 1.68805803 |
| 155 | Genetic anticipation (HP:0003743) | 1.68252738 |
| 156 | Abnormality of the calf musculature (HP:0001430) | 1.67937373 |
| 157 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.67513048 |
| 158 | Abnormal gallbladder morphology (HP:0012437) | 1.67417410 |
| 159 | Flat cornea (HP:0007720) | 1.67302512 |
| 160 | Myokymia (HP:0002411) | 1.67060467 |
| 161 | Abnormality of dentin (HP:0010299) | 1.66977825 |
| 162 | Facial shape deformation (HP:0011334) | 1.66781750 |
| 163 | Potter facies (HP:0002009) | 1.66781750 |
| 164 | Elbow flexion contracture (HP:0002987) | 1.66297590 |
| 165 | Vascular calcification (HP:0004934) | 1.66127669 |
| 166 | Striae distensae (HP:0001065) | 1.65911788 |
| 167 | Cardiovascular calcification (HP:0011915) | 1.63814905 |
| 168 | Wide anterior fontanel (HP:0000260) | 1.62975775 |
| 169 | Asymmetric septal hypertrophy (HP:0001670) | 1.62287765 |
| 170 | Pigmentary retinal degeneration (HP:0001146) | 1.61603270 |
| 171 | Aortic regurgitation (HP:0001659) | 1.61195095 |
| 172 | Hemiplegia (HP:0002301) | 1.60491069 |
| 173 | Osteolytic defects of the hand bones (HP:0009699) | 1.59983247 |
| 174 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.59983247 |
| 175 | Abnormal social behavior (HP:0012433) | 1.59362252 |
| 176 | Impaired social interactions (HP:0000735) | 1.59362252 |
| 177 | Epileptic encephalopathy (HP:0200134) | 1.59310701 |
| 178 | Dilatation of the ascending aorta (HP:0005111) | 1.59064782 |
| 179 | Postural instability (HP:0002172) | 1.58996611 |
| 180 | Heart block (HP:0012722) | 1.57814325 |
| 181 | Long toe (HP:0010511) | 1.57510408 |
| 182 | Short nail (HP:0001799) | 1.56946949 |
| 183 | Renal duplication (HP:0000075) | 1.56734271 |
| 184 | Hypercortisolism (HP:0001578) | 1.56699853 |
| 185 | Knee flexion contracture (HP:0006380) | 1.56096568 |
| 186 | Hip contracture (HP:0003273) | 1.55259129 |
| 187 | Distal lower limb amyotrophy (HP:0008944) | 1.53549892 |
| 188 | Complete atrioventricular canal defect (HP:0001674) | 1.52318983 |
| 189 | Limb-girdle muscle weakness (HP:0003325) | 1.51730623 |
| 190 | Infantile muscular hypotonia (HP:0008947) | 1.51515441 |
| 191 | Hyperparathyroidism (HP:0000843) | 1.50891787 |
| 192 | Tibial bowing (HP:0002982) | 1.50891037 |
| 193 | Muscle fiber splitting (HP:0003555) | 1.49374723 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MUSK | 3.57774749 |
| 2 | LATS1 | 2.81513090 |
| 3 | INSRR | 2.77943220 |
| 4 | SIK1 | 2.44190597 |
| 5 | EPHA4 | 2.35766413 |
| 6 | NTRK3 | 2.14025628 |
| 7 | SGK2 | 2.12473544 |
| 8 | TTN | 2.10117448 |
| 9 | CASK | 1.96407213 |
| 10 | FGFR2 | 1.89799188 |
| 11 | NTRK2 | 1.87517539 |
| 12 | SGK494 | 1.86550200 |
| 13 | SGK223 | 1.86550200 |
| 14 | MAP3K4 | 1.83598531 |
| 15 | SGK3 | 1.82253764 |
| 16 | PTK2 | 1.80991288 |
| 17 | MAP2K4 | 1.78282401 |
| 18 | CAMK1G | 1.71954600 |
| 19 | DAPK2 | 1.70976909 |
| 20 | MYLK | 1.68950544 |
| 21 | BCKDK | 1.68179006 |
| 22 | AKT3 | 1.67430181 |
| 23 | CDK12 | 1.66509353 |
| 24 | PRKD3 | 1.66051630 |
| 25 | ERBB4 | 1.64671192 |
| 26 | FGFR4 | 1.61261805 |
| 27 | MARK1 | 1.57951439 |
| 28 | PINK1 | 1.54898417 |
| 29 | EEF2K | 1.49427390 |
| 30 | MAP2K7 | 1.46706614 |
| 31 | TNIK | 1.46326563 |
| 32 | CAMK1D | 1.43640288 |
| 33 | MET | 1.37611978 |
| 34 | PHKG2 | 1.35933206 |
| 35 | PHKG1 | 1.35933206 |
| 36 | STK38 | 1.32944509 |
| 37 | ARAF | 1.31380275 |
| 38 | ICK | 1.25649843 |
| 39 | PAK2 | 1.25488155 |
| 40 | KSR2 | 1.24888835 |
| 41 | NEK9 | 1.24282375 |
| 42 | WNK3 | 1.21580824 |
| 43 | FRK | 1.18481022 |
| 44 | LIMK1 | 1.17741020 |
| 45 | TRIB3 | 1.16536942 |
| 46 | PAK6 | 1.15818481 |
| 47 | MTOR | 1.15238757 |
| 48 | PRKD2 | 1.15191408 |
| 49 | RIPK1 | 1.14107649 |
| 50 | MOS | 1.12961463 |
| 51 | CAMK2B | 1.11522105 |
| 52 | PDGFRB | 1.09532581 |
| 53 | TRPM7 | 1.09095754 |
| 54 | TESK1 | 1.08004191 |
| 55 | WNK4 | 1.06127019 |
| 56 | MAP3K13 | 1.02529116 |
| 57 | PRKCH | 1.00993509 |
| 58 | NTRK1 | 1.00922647 |
| 59 | CAMK2G | 0.99879528 |
| 60 | MINK1 | 0.97357806 |
| 61 | LMTK2 | 0.96890896 |
| 62 | PDK3 | 0.95836717 |
| 63 | PDK4 | 0.95836717 |
| 64 | MAP3K7 | 0.95510824 |
| 65 | PKN1 | 0.91463392 |
| 66 | PRPF4B | 0.90725298 |
| 67 | PRKAA2 | 0.89836104 |
| 68 | EPHA3 | 0.87138520 |
| 69 | SCYL2 | 0.85334078 |
| 70 | ROCK2 | 0.83783938 |
| 71 | PRKCG | 0.83662612 |
| 72 | CAMKK1 | 0.81020337 |
| 73 | RPS6KA2 | 0.81010036 |
| 74 | NUAK1 | 0.80978932 |
| 75 | OXSR1 | 0.80615379 |
| 76 | MAPK12 | 0.80135409 |
| 77 | DMPK | 0.79777108 |
| 78 | PRKAA1 | 0.79290530 |
| 79 | UHMK1 | 0.78302595 |
| 80 | STK38L | 0.78196628 |
| 81 | FGFR3 | 0.77266048 |
| 82 | CAMK2D | 0.74921315 |
| 83 | PDK2 | 0.74264044 |
| 84 | MAPK13 | 0.74227929 |
| 85 | RET | 0.73873985 |
| 86 | CDC42BPA | 0.73848050 |
| 87 | SGK1 | 0.73432430 |
| 88 | MAP2K1 | 0.73392985 |
| 89 | FER | 0.72011727 |
| 90 | PDGFRA | 0.71427912 |
| 91 | EPHB2 | 0.70560703 |
| 92 | MELK | 0.70515282 |
| 93 | MAP3K9 | 0.70194421 |
| 94 | MAP3K6 | 0.69560015 |
| 95 | PAK3 | 0.68990127 |
| 96 | TYRO3 | 0.68930932 |
| 97 | CDK5 | 0.68505277 |
| 98 | MAPKAPK3 | 0.67042931 |
| 99 | CAMK1 | 0.65421387 |
| 100 | CAMK2A | 0.65411607 |
| 101 | TIE1 | 0.65124822 |
| 102 | PRKCZ | 0.64866209 |
| 103 | CAMK4 | 0.64821049 |
| 104 | PTK2B | 0.64532832 |
| 105 | IRAK2 | 0.64135860 |
| 106 | MAPK10 | 0.62765986 |
| 107 | ERN1 | 0.62499677 |
| 108 | MARK2 | 0.62150489 |
| 109 | TAOK3 | 0.60540319 |
| 110 | CDK19 | 0.59303463 |
| 111 | MAPK7 | 0.58274733 |
| 112 | WNK1 | 0.57840482 |
| 113 | DYRK1A | 0.56406137 |
| 114 | MAP3K1 | 0.56403300 |
| 115 | PIK3CA | 0.56340638 |
| 116 | MAPK11 | 0.55847528 |
| 117 | PRKCE | 0.54481839 |
| 118 | LATS2 | 0.54299290 |
| 119 | PKN2 | 0.54085163 |
| 120 | PRKACG | 0.53283702 |
| 121 | OBSCN | 0.52512840 |
| 122 | IRAK1 | 0.52388089 |
| 123 | PDK1 | 0.52065766 |
| 124 | KSR1 | 0.52041327 |
| 125 | RPS6KA3 | 0.51344618 |
| 126 | GRK5 | 0.50511291 |
| 127 | STK11 | 0.50187346 |
| 128 | CSNK1G2 | 0.49578669 |
| 129 | PRKD1 | 0.48860516 |
| 130 | PDPK1 | 0.48730821 |
| 131 | ABL2 | 0.48583736 |
| 132 | DDR2 | 0.48480708 |
| 133 | BRAF | 0.48319668 |
| 134 | ROCK1 | 0.47540351 |
| 135 | ERBB2 | 0.47442240 |
| 136 | EPHB1 | 0.47063146 |
| 137 | MAP3K2 | 0.46995905 |
| 138 | NEK6 | 0.46289209 |
| 139 | MST1R | 0.45556102 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.24544706 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.30238857 |
| 3 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.53123815 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.49719133 |
| 5 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.40854292 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.36013149 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.30005799 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.15939767 |
| 9 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.05706319 |
| 10 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.01182130 |
| 11 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.01072021 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.97251533 |
| 13 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.90934040 |
| 14 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.89650166 |
| 15 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.88092529 |
| 16 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.85871806 |
| 17 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.83399095 |
| 18 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.82218294 |
| 19 | Bile secretion_Homo sapiens_hsa04976 | 1.69265827 |
| 20 | Peroxisome_Homo sapiens_hsa04146 | 1.63084617 |
| 21 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.59823739 |
| 22 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.58410412 |
| 23 | Focal adhesion_Homo sapiens_hsa04510 | 1.57938769 |
| 24 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.49922190 |
| 25 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.49089535 |
| 26 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.44550456 |
| 27 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.34624993 |
| 28 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.29435205 |
| 29 | Glioma_Homo sapiens_hsa05214 | 1.27134298 |
| 30 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.26561062 |
| 31 | Gap junction_Homo sapiens_hsa04540 | 1.26416035 |
| 32 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.24755116 |
| 33 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.22118369 |
| 34 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.19917315 |
| 35 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.19583405 |
| 36 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.16247026 |
| 37 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.15425914 |
| 38 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.14817474 |
| 39 | ABC transporters_Homo sapiens_hsa02010 | 1.12589155 |
| 40 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.11542851 |
| 41 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.10555126 |
| 42 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.08603342 |
| 43 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.08447581 |
| 44 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.07879055 |
| 45 | Nicotine addiction_Homo sapiens_hsa05033 | 1.05061115 |
| 46 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.04984609 |
| 47 | Prion diseases_Homo sapiens_hsa05020 | 1.04741671 |
| 48 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.03913546 |
| 49 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.02936370 |
| 50 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.01863035 |
| 51 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.01378564 |
| 52 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.00813032 |
| 53 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.00716740 |
| 54 | Lysine degradation_Homo sapiens_hsa00310 | 1.00367913 |
| 55 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.99755524 |
| 56 | GABAergic synapse_Homo sapiens_hsa04727 | 0.97010660 |
| 57 | Retinol metabolism_Homo sapiens_hsa00830 | 0.96393418 |
| 58 | Histidine metabolism_Homo sapiens_hsa00340 | 0.95587072 |
| 59 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.93916379 |
| 60 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.93764850 |
| 61 | Melanogenesis_Homo sapiens_hsa04916 | 0.91964640 |
| 62 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.90916784 |
| 63 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.90579275 |
| 64 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.89711955 |
| 65 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.89323561 |
| 66 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.87134632 |
| 67 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.86606953 |
| 68 | Adherens junction_Homo sapiens_hsa04520 | 0.86335370 |
| 69 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.86290816 |
| 70 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.86000456 |
| 71 | Circadian entrainment_Homo sapiens_hsa04713 | 0.85014696 |
| 72 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.83931496 |
| 73 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.83834806 |
| 74 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.83755602 |
| 75 | Insulin secretion_Homo sapiens_hsa04911 | 0.83447929 |
| 76 | Endometrial cancer_Homo sapiens_hsa05213 | 0.82265688 |
| 77 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.82251542 |
| 78 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.81083971 |
| 79 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.80968892 |
| 80 | Long-term depression_Homo sapiens_hsa04730 | 0.80960465 |
| 81 | Amoebiasis_Homo sapiens_hsa05146 | 0.80270705 |
| 82 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.80015777 |
| 83 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.79747260 |
| 84 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.76994963 |
| 85 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.75679228 |
| 86 | Melanoma_Homo sapiens_hsa05218 | 0.74950371 |
| 87 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.74342144 |
| 88 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.73432319 |
| 89 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.73189810 |
| 90 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.71752302 |
| 91 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.71431946 |
| 92 | Axon guidance_Homo sapiens_hsa04360 | 0.70932758 |
| 93 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.70561468 |
| 94 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.68598115 |
| 95 | Circadian rhythm_Homo sapiens_hsa04710 | 0.68363398 |
| 96 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.67678532 |
| 97 | Morphine addiction_Homo sapiens_hsa05032 | 0.67220590 |
| 98 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.66974471 |
| 99 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.66958692 |
| 100 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.66200278 |
| 101 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.65710900 |
| 102 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.65489532 |
| 103 | Carbon metabolism_Homo sapiens_hsa01200 | 0.65307059 |
| 104 | Tight junction_Homo sapiens_hsa04530 | 0.64709485 |
| 105 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.63673600 |
| 106 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.63602965 |
| 107 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.63093698 |
| 108 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.62992469 |
| 109 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.62311212 |
| 110 | Taste transduction_Homo sapiens_hsa04742 | 0.62247780 |
| 111 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.61906859 |
| 112 | Salivary secretion_Homo sapiens_hsa04970 | 0.61437529 |
| 113 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.61430798 |
| 114 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.59528477 |
| 115 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.59451144 |
| 116 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.58406486 |
| 117 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.56638498 |
| 118 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.56634467 |
| 119 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.56440585 |
| 120 | Renin secretion_Homo sapiens_hsa04924 | 0.56381406 |
| 121 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.55931552 |
| 122 | Olfactory transduction_Homo sapiens_hsa04740 | 0.55640002 |
| 123 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.55485131 |
| 124 | Insulin resistance_Homo sapiens_hsa04931 | 0.54642506 |
| 125 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.54283685 |
| 126 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.54096547 |
| 127 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.53996201 |
| 128 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.53959724 |
| 129 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.53614795 |
| 130 | Long-term potentiation_Homo sapiens_hsa04720 | 0.49829127 |
| 131 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.49779705 |
| 132 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.48408470 |
| 133 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.47344323 |
| 134 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.46652116 |
| 135 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.46397083 |
| 136 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.45240502 |
| 137 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.43969006 |
| 138 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.43337089 |
| 139 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.42586300 |
| 140 | Cocaine addiction_Homo sapiens_hsa05030 | 0.41624587 |
| 141 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.41264506 |
| 142 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.40514066 |
| 143 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.39801898 |
| 144 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.38783453 |
| 145 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.38746254 |
| 146 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.37578151 |
| 147 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.36471683 |
| 148 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.36392815 |
| 149 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.33300253 |
| 150 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.32277126 |
| 151 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.31885593 |

